scispace - formally typeset
D

Diederick E. Grobbee

Researcher at Utrecht University

Publications -  1108
Citations -  136069

Diederick E. Grobbee is an academic researcher from Utrecht University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 155, co-authored 1051 publications receiving 122748 citations. Previous affiliations of Diederick E. Grobbee include National Heart Foundation of Australia & Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study

TL;DR: Although the incidence rate is higher in men than in women over the entire age range, the lifetime risks were similar for both sexes, and the survival after stroke did not differ according to sex.
Journal ArticleDOI

Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study.

TL;DR: The association between common carotid intima-media thickness and lower extremity arterial atherosclerosis among the first 1000 participants of the Rotterdam Study was studied and adjustments for differences in serum lipids, hypertension, and current smoking status only slightly attenuated the results.
Journal ArticleDOI

The effect of outpatient preoperative evaluation of hospital inpatients on cancellation of surgery and length of hospital stay.

TL;DR: The use of OPE for potential inpatients leads to a significant reduction of cancelled cases and of length of admission, and further increase of these benefits from OPE requires changes in institutional policy, such as forcing surgical departments to increase their number of same-day admissions.
Journal ArticleDOI

Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study.

TL;DR: An unfavorable cardiovascular risk profile is associated with a marked increase in CCIMT in young adulthood and efforts to change modifiable risk factors early in life may retard atherosclerosis development and hence delay the onset of clinical cardiovascular disease later in life.